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Wnt signallingRelated transcription factors of the POU protein family show extensive overlap of expression in vivo and
exhibit very similar biochemical properties in vitro. To study functional equivalence of class III POU proteins
in vivo, we exchanged the Oct-6 gene by Brn-1 in the mouse. Brn-1 can fully replace Oct-6 in Schwann cells
and rescue peripheral nervous system development in these mice. The same mice, however, exhibit severe
defects in forebrain development arguing that Oct-6 and Brn-1 are not functionally equivalent in the central
nervous system. The cause of the observed forebrain phenotype is complex, but anteriorly expanded Wnt1
expression contributes. Oct-6 normally represses Wnt1 expression in the early diencephalon and
replacement by Brn-1 as a weaker inhibitor is no longer sufﬁcient to maintain the necessary level of
repression in the mouse mutant. The extent of functional equivalence between related transcription factors is
thus strongly dependent on the analyzed tissue.
© 2009 Elsevier Inc. All rights reserved.Introduction
The POU family represents a large group of transcription factors
that possess as their hallmark a composite DNA-binding domain that
consists of a variant homeodomain preceded by a POU-speciﬁc
domain (Ryan and Rosenfeld, 1997; Wegner et al., 1993). The POU
family can furthermore be subdivided in groups according to the
similarity of its members to each other. One such group, the class III,
consists of Brn-1, Brn-2, Brn-4 and Oct-6 (Hara et al., 1992; He et al.,
1989). These class III POUproteins exhibit not only extensive sequence
similarities on the amino acid level, they also show overlapping
expression patterns (Alvarez-Bolado et al., 1995; He et al., 1989) as
well as similar DNA binding, subcellular localization and transactiva-
tion characteristics in vitro (Baranek et al., 2005; Schreiber et al., 1997;
Sock et al., 1996).
As a consequence, substantial functional redundancy should exist
between different class III proteins. Evidence for such a redundancy
has for instance been obtained in mice in which deletions of multiple
class III POU proteins led to defects not observed in mice with single
gene deletions. Production, migration and positioning of cortical
neurons are, for instance, strongly affected in Brn-1/Brn-2 double-(M. Wegner).
l rights reserved.deﬁcient mice, but not in mice in which only Brn-1 or Brn-2 is deleted
(McEvilly et al., 2002; Sugitani et al., 2002).
Nevertheless, developmental defects are also observed in mice
with deletions of single class III genes. Brn-1 deﬁcient mice, for
instance, suffer from kidney malformations (Nakai et al., 2003), and
development of the endocrine hypothalamus is selectively affected in
Brn-2 deﬁcient mice (Nakai et al., 1995; Schoneman et al., 1995). Oct-6
deﬁcient mice, on the other hand, present with a glial defect in
peripheral nervous system (PNS) development, as Schwann cells are
arrested at the promyelin stage and peripheral myelination is strongly
delayed (Bermingham et al., 1996; Jaegle et al., 1996). Other
phenotypes include migration defects of select neuronal populations
of the central nervous system (CNS) that lead to mislocalization of
brain nuclei including some involved in breathing control (Berming-
ham et al., 1996).
These phenotypes in mice with single gene deletions correlate
with the unique or at least preferential expression of one class III POU
protein in the tissue or cell type that is affected. Schwann cells, for
instance, express high levels of Oct-6, much lower Brn-2 levels, and
none of the other class III proteins. As a consequence Oct-6 deﬁcient
mice exhibit a Schwann cell defect, whereas loss of Brn-2 is
compensated and thus inapparent in Schwann cells of Brn-2 deﬁcient
mice. The fact that loss of both Oct-6 and Brn-2 strongly aggravates the
Schwann cell defect, further substantiates the notion that class III POU
proteins act in a highly similar manner (Jaegle et al., 2003).
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class III POU proteins, we have previously generatedmice inwhich we
replaced the continuous Oct-6 open reading frame by the Brn-1 open
reading frame, thereby generating the Oct-6brn-1 allele (Friedrich et al.,
2005). This allele allows expression of Brn-1 in all cells and tissues
that normally express Oct-6, at comparable levels. Analysis on amixed
C57Bl/6J-129Sv background revealed that Brn-1 was capable of
completely rescuing the Schwann cell defect in Oct-6brn-1/brn-1 as
well as in Oct-6brn-1/− mice (Friedrich et al., 2005). This strongly
suggested that Oct-6 and Brn-1 are functionally very similar, if not
equivalent at least with respect to their role in PNS development.
When backcrossing the Oct-6brn-1 allele on a C57Bl/6J background,
we noticed, however, that Oct-6brn-1/brn-1 animals were born in
increasingly lower numbers, whereas Oct-6brn-1/− mice continued to
be born at Mendelian ratios, were phenotypically inapparent, fertile
and still without an obvious Schwann cell phenotype. This pointed to
selective embryonic lethality in the Oct-6brn-1/brn-1 genotype on a
clean genetic background.
Here we report that these Oct-6brn-1/brn-1 mice suffer from severe
forebrain truncations that are neither commonly observed inOct-6−/−
nor in Oct-6brn-1/− mice. We furthermore provide evidence that the
differential inﬂuence of Brn-1 versus Oct-6 on Wnt1 expression leads
to an anteriorly expandedWnt1 expression inOct-6brn-1/brn-1mice that
is at least in part responsible for the observed phenotype. Our results
thus provide evidence that class III POU proteins are functionally
equivalent only during PNS, but not during CNS development.
Materials and methods
Animal husbandry, genotyping, tissue preparation, histological staining,
in situ hybridization, proliferation and apoptosis assays
Mice with an Oct-6brn-1 (Friedrich et al., 2005) or an Oct-6–
(Bermingham et al., 1996) allele were bred on a C57Bl/6J background
and kept as heterozygotes. Genotyping was performed by PCR as
described (Berminghamet al.,1996; Friedrich et al., 2005). Homozygous
mutants were generated by intercrosses of Oct-6+/brn-1 or Oct-6+/–
animals, respectively. For some experiments, the Sox8lacZ allele (Sock et
al., 2001)was additionally crossed into themice to provide a lacZmarker
that labels the cranial neural crest in the head region. Embryos were
obtained from 9.5 to 18.5 days post coitum (dpc), photographed and
processed.
For whole mount in situ hybridizations, embryos were ﬁxed
overnight at 4°C in 4% paraformaldehyde, dehydrated, bleached, and
rehydrated. In situ hybridization was performed essentially as
described (Britsch et al., 2001) with antisense riboprobes for Brn-1,
Oct-6 (Schreiber et al., 1997), Brn-2, Six3 (gifts of Q. Ma, Dana Farber
Cancer Institute, Boston), Emx1, Emx2 (gifts of J. Rubenstein, UCSF, San
Francisco), En1 (gift ofW.Wurst, Helmholtz-Zentrum, München), Fgf8
(gift of G. Martin, UCSF, San Francisco), HoxB1, Wnt1 and Wnt3a (gifts
of A. Joyner, Memorial Sloan-Kettering Cancer Center, New York),
Mash1 (gift of F. Guillemot, NIMR, Mill Hill), Shh (gift of A. MacMahon,
Harvard University, Cambridge), Bmp4 (gift of B. Hogan, Duke
University Medical Center, Durham) and Pax6 (gift of D. Engelkamp,
Erlangen). Riboprobes were routinely DIG-labelled. For double in situ
hybridization, ﬂuorescein-labelled probes were additionally used. All
steps except probe hybridization and ﬁnal colorimetric detection using
NBT/BCIP or Fast Red (Roche) were performed automatically on a
Biolane HTI (Hölle and Hüttner AG, Tübingen, Germany).
Detection of β-galactosidase activity in whole mount embryos
followed standard procedures (Britsch et al., 2001). After overnight
ﬁxation in 1% paraformaldehyde, embryos were incubated for several
hours at 37°C in 1% X-gal until blue precipitates were detectable.
For HE staining, embryos were thoroughly and repeatedly washed
in tapwater after ﬁxation, dehydrated in a series of graded alcohol and
embedded in parafﬁn. HE staining was carried out on 2 μm-thicksagittal parafﬁn sections. Analysis and documentation was with a
Leica MZFLIII stereomicroscope equipped with an Axiocam (Zeiss,
Oberkochem, Germany).
For proliferation studies, pregnant mice were injected intraper-
itoneally with 100 μg BrdU (Sigma) per gram body weight 1 h before
embryo preparation (Stolt et al., 2003). Embryos underwent ﬁxation
in 4% paraformaldehyde, were frozen at −80 °C in Jung Tissue
Freezing Medium (Leica, Nussloch, Germany) and sectioned sagitally
on a cryotome at 14-μm thickness. Incorporated BrdU was visualized
by an Alexa-488 coupledmousemonoclonal antibody directed against
BrdU (Molecular Probes) at a 1:20 dilution as a measure of
proliferation. TUNEL assays were performed on cryosections accord-
ing to the manufacturer`s protocol (Chemicon).
Cell culture, transfection, extract preparation, electrophoretic mobility
shift assays and luciferase assays
HEK 293 cells were maintained in DMEM containing 10% FCS and
transfected on 10-cm dishes with 10 μg pCMV5-based expression
plasmids for full length Oct-6 and Brn-1 as well as truncated versions
Oct-6ΔNC (Sock et al., 1996) and Brn-1ΔN (Schreiber et al., 1997) using
Superfect reagent (Qiagen). Transfected cells were harvested 48 h
posttransfection and used to prepare whole cell protein extracts as
previously described (Baranek et al., 2005). These extracts were
incubated for electrophoretic mobility shift assays with 32P-labelled
oligonucleotides containing the sequence of the putative Oct-6 binding
site at −1466 or at −955 of the Wnt1 promoter and poly(dIdC) as
unspeciﬁc competitor. Samples were loaded on to native 5% polyacry-
lamide gels and electrophoresed in 45 mM Tris, 45 mM boric acid and
1mMEDTA (pH 8.3) at 120 V for 1.5 h. Gels were dried and exposed for
autoradiography.
For luciferase assays, HEK 293 cells were transfected transiently in
duplicates in 24-well plates with 500 ng of luciferase reporter plasmid
and 100 ng of effector plasmids per well. Luciferase reporters
contained the Wnt1 promoter region in a short (positions −1234 to
+34, psWnt-luc) or a long (positions −1566 to +34, plWnt-luc)
version and were based on the pGL2 backbone (Promega, Madison,
WI). The short version of the Wnt1 promoter was additionally
combined in psWnt-luc-enh with the 3′ neural plate enhancer of
the Wnt1 gene (positions +7744 to +8837) (Rowitch et al., 1998)
which was inserted behind the luciferase reporter gene. Mutations
were additionally introduced into plWnt-luc to destroy both Oct-6
binding sites, leading to the plWnt-delOct-luc reporter plasmid.
Effector plasmids corresponded to pCMV5-based expression plasmids
for Brn-1, Brn-2 and Oct-6 and have been described before (Schreiber
et al., 1997; Sock et al., 1996). Cells were harvested 48 h posttransfec-
tion and activities were determined as described (Renner et al., 1994).
Chromatin immunoprecipitation
Chromatin immunoprecipitation assays on embryonic brain was
performed as described (Stolt et al., 2006). Brieﬂy, whole brain tissue
of 10.5 dpc-old embryos was dissociated by trituration. Consecutively,
cellular protein and genomic DNAwere crosslinked by treatment with
1% formaldehyde before chromatin extraction and soniﬁcation to an
average fragment length of 300 to 600 bp. Immunoprecipitationswere
performed overnight at 4°C using polyclonal IgG against Oct-6
(Baranek et al., 2005; Sock et al., 1996) or Brn-1 (Friedrich et al.,
2005) as well as control IgG fractions. DNA was puriﬁed from
precipitates after crosslink reversal and subjected to PCR. For
detection of a fragment containing the Oct-6 binding site in the
Wnt1 promoter at position −1466, 5′-ACTGCAGAAACCTGGGAGAA-3′
(position −1566 to −1586) and 5′-GTTCTCAGCACCCAAGTGGT-3′
(position −1312 to −1332) were used as primers in 33 cycles of
standard PCR using an annealing temperature of 60°C. The fragment
around the second Oct-6 binding site at −955 was detected with 5′-
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GACAGGAGACGTCCAGAAGG-3′ (position −768 to −788) as primers.
Results
Oct-6brn-1/brn-1 mice suffer from severe forebrain truncations
When backcrossing the Oct-6brn-1 allele on a C57Bl/6J background,
Oct-6brn-1/brn-1 newborns became increasingly underrepresented
arguing for embryonic lethality in this genotype. To identify the
potential cause for this embryonic lethality, we performed timed
matings. Oct-6brn-1/brn-1 embryos exhibited severe brain malforma-
tions already at 10.5 dpc (Figs. 1A–D). These brain malformations
continued to be seen throughout embryonic development (Figs. 1E–T)
until 18.5 dpc (Figs. 1U–X). The percentage of Oct-6brn-1/brn-1 embryos,
however, became lower with increasing ages. The severity of the
observed brain malformations also varied substantially (compare for
instance Figs. 1C, D with Figs. 1G, H). In general, the phenotype
worsened with increased backcrossing. Intriguingly, these defects
were not commonly observed in Oct-6−/− or in Oct-6brn-1/− mice
(Bermingham et al., 1996; Friedrich et al., 2005).
In common to all affected embryos was a truncation of the
forebrain. By histology, diencephalon and telencephalon appeared toFig. 1. Appearance of Oct-6brn-1/brn-1 embryos. Compared to wildtype littermates (A, B, E, F, I,
forebrain malformations that are visible on 10.5 dpc (A–D), 11.5 dpc (E–H), 12.5 dpc (I–L), 14.
an external lateral view of the embryo, whereas panels B, C, F, G, J, K, N, O, R, S, V, W reprebe absent in the severe cases. Other facial structures were con-
comitantly malformed. In the milder cases, only the anterior part of
the telencephalon was affected. Other parts of the body appeared
superﬁcially normal. We therefore concentrated on the brain
malformation for further analyses.
Expression of forebrain markers is strongly reduced in Oct-6brn-1/brn-1
embryos
To characterize the defect in further detail, we performed whole
mount in situ hybridizations with several region-speciﬁc brain markers.
At 9.5 dpc, Pax6 is expressed throughout the complete forebrain
(Walther and Gruss, 1991) as evident for the wildtype (Fig. 2A). In
Oct-6brn-1/brn-1 embryos, by contrast, the Pax6 expressing region is
variably, but severely reduced (Figs. 2B, C).
Emx1 as a telencephalic marker (Simeone et al., 1992) starts to be
expressed in wildtype embryos at 9.5 dpc (Fig. 2D), but not in the
majority of affected Oct-6brn-1/brn-1 embryos (Figs. 2E, F) arguing that
the telencephalon is most severely impaired in its development by the
mutation. Similar results were also obtained in whole mount in situ
hybridizations with Emx2 as probe (data not shown). Despite the
strong forebrain defect in Oct-6brn-1/brn-1 embryos, we did not detect
any signiﬁcant alteration in the proliferation rate at 9.5 dpc in BrdUJ, M, N, Q, R, U, V), Oct-6brn-1/brn-1 embryos (C, D, G, H, K, L, O, P, S, T, W, X) exhibit severe
5 dpc (M–P), 16.5 dpc (Q–T) and 18.5 dpc (U–X). Panels A, D, E, H, I, L, M, P, Q, T, U, X give
sent HE-stained midsagittal sections.
Fig. 2. Expression of fore- andmidbrainmarkers inOct-6brn-1/brn-1 embryos at 9.5 dpc and11.5dpc.Wholemount in situ hybridizationswereperformedonwildtype (A,D,G, J, A′, D′, G′, ,J′)
andOct-6brn-1/brn-1 (B, C, E, F, H, I, K, L, B′, C′, E′, F′, H′, I′, K′, L′) embryos at 9.5 dpc (A–L) and 11.5 dpc (A′–L′) using antisense riboprobes against Pax6 (A–C, A′–C′), Emx1 (D–F, D′–F′), Emx2
(inlays in D′, E′), Shh (G–I, G′–I′) andMash1 (J–L, J′–L′). Lateral views are presented. Differently affected Oct-6brn-1/brn-1 embryos are shown for each marker to give an impression of the
phenotypic variability.
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BrdUwithin 1 h in thewildtype compared to 63% in the Oct-6brn-1/brn-1
embryo. Rates of apoptotic cells as determined in TUNEL assays were
also comparable with 1.25% in the wildtype versus 0.85% in the Oct-
6brn-1/brn-1 forebrain.
Conﬁrming the forebrain defect, Shh expression also rarely extended
rostrally beyond the zona limitans intrathalamica (ZLI) inOct-6brn-1/brn-1
embryos (Figs. 2H, I). Caudal to the ZLI, however, Shh expression was
unchanged in the mutant (compare Figs. 2H, I to Fig. 2G) arguing that
more caudal brain regions are less dramatically affected. In line with
such an assumption, Mash1 staining in Oct-6brn-1/brn-1 embryos at 9.5
dpc resembled that in thewildtype (Figs. 2J–L). AsMash1predominantly
stains the midbrain at this age (Guillemot and Joyner, 1993), this brain
territory looks relatively normal in Oct-6brn-1/brn-1 embryos.
When the samemarkerswere appliedonwildtype andOct-6brn-1/brn-1
embryos at 11.5 dpc, generally similar results were obtained. There were
signiﬁcant reductions in the expression of Emx1 and Emx2 as tele-
ncephalic markers (Figs. 2D′–F′). Forebrain expressionwas also reduced
for Pax6 as an alar plate marker (Figs. 2A′–C′) and Shh as a basal plate
marker (Figs. 2G′–I′) thus indicating that the dorsal and ventral forebrain
were both affected. Mash-1 staining, in contrast, was still comparable
betweenOct-6brn-1/brn-1 andwildtype embryos (Figs. 2J′–L′) arguing that
the midbrain continues to develop fairly normally.
Mid- and hindbrain development is only mildly disturbed in
Oct-6brn-1/brn-1 embryos
To study posterior brain development in more detail, we also
analyzed Fgf8 expression which marks the isthmic organizer at theborder between mid- and hindbrain. In wildtype embryos, Fgf8 was
expressed in a sharp stripe at both 9.5 dpc and 11.5 dpc (Figs. 3A, A′).
Borders of the Fgf8-positive territoryweremore diffuse inOct-6brn-1/brn-1
embryos at both time points, and the expression domainwas expanded
rostrally into the midbrain region (Figs. 3B, C, B′). A similar expansion
was also observed at both 9.5 dpc and 11.5 dpc for En1 (Figs. 3D–F andC′,
D′) which marks a territory slightly broader than Fgf8 and is involved in
mid-hindbrainpatterning (Davis and Joyner,1988).HoxB1 as amarker of
rhombomere 4was comparably expressed in the hindbrains of wildtype
andOct-6brn-1/brn-1 embryos (Figs. 3G–I and E′, F′). If anything, theHoxB1
expression domainwas slightly expanded in theOct-6brn-1/brn-1 embryos.
These results indicate that marker gene expression in mid- and
hindbrain of Oct-6brn-1/brn-1 embryos is also altered, but that alterations
are much less dramatic than in the forebrain region. This conclusion is
also corroborated by the fact that the anterior neural ridge as a site of
Fgf8 expression in the wildtype forebrain was absent in Oct-6brn-1/brn-1
embryos (Figs. 3A–C).
Cranial neural crest is normally generated in Oct-6brn-1/brn-1 embryos
As the more strongly affected Oct-6brn-1/brn-1 embryos also
exhibited other facial malformations, we next studied the cranial
neural crest which is the source of many facial structures. For this
purpose, we took advantage of the fact that the transcription factor
Sox8 is broadly expressed throughout the early cranial neural crest and
that β-galactosidase expressed from a Sox8lacZ allele mimicks this
expression (Sock et al., 2001). We thus introduced the Sox8lacZ allele
into Oct-6brn-1/brn-1 embryos and compared the β-galactosidase
staining in this mouse mutant to Oct-6+/+ embryos at both 9.5 dpc
Fig. 3. Expression of isthmic organizer and hindbrainmarkers in Oct-6brn-1/brn-1 embryos. Wholemount in situ hybridizations were performed onwildtype (A, D, G, A′, C′, E′) and Oct-
6brn-1/brn-1 (B, C, E, F, H, I, B′, D′, F′) embryosat 9.5 dpc (A–I) and11.5dpc (A′–F′) using antisense riboprobes against Fgf8 (A–C, A′, B′),En1 (D–F, C′, D′) andHoxB1 (G–I, E′, F′). Lateral views
are presented at 9.5 dpc, top views at 11.5 dpc. Differently affected Oct-6brn-1/brn-1 embryos are shown for each marker at 9.5 dpc to give an impression of the phenotypic variability.
422 M. Wolf et al. / Developmental Biology 332 (2009) 418–428(Figs. 4A–F) and 11.5 dpc (Figs. 4A′–F′). Cranial neural crest cells
predominantly originate in the hind- and midbrain regions (Fig. 4A).
There was no signiﬁcant difference in cranial neural crest appearance
between Oct-6+/+ and Oct-6brn-1/brn-1 embryos with regard to
timing or location (Figs. 4A–C). Cranial neural crest furthermore
migrated normally into the branchial arches (Figs. 4A–C and A′–C′).
Rostral migration of cranial neural crest cells was, however, stalled in
Oct-6brn-1/brn-1 embryos at 11.5 dpc, resulting in an accumulation of
cranial neural crest cells in the midbrain region and a reduction ofFig. 4. Development of the cranial neural crest in Oct-6brn-1/brn-1 embryos. To follow cranial
embryos at 9.5 dpc (A–F) and 11.5 dpc (A′–F′), a Sox8lacZ allele was additionally introduced
A′–C′ represent lateral views of the stained head regions, panels D–F and D′–F′ are ma
Differently affected Oct-6brn-1/brn-1 embryos are shown to give an impression of the phenocranial neural crest cell numbers in the frontonasal process
(compare Figs. 4B′, C′ to Fig. 4A′). From the fact that cranial
neural crest is generated normally (Fig. 4) and does not express
signiﬁcant levels of Oct-6 (Figs. 7A, A′), it appears likely that these
latter defects are secondary to the forebrain defect.
Interestingly, β-galactosidase also stained brain cells that in
Oct-6+/+ embryos were exactly localized at the border between
forebrain and midbrain (Figs. 4D and D′). This staining was strongly
reduced or completely absent in all analyzed Oct-6brn-1/brn-1 embryosneural crest cells in Oct-6+/+ (A, D, A′, D′) and Oct-6brn-1/brn-1 (B, C, E, F, B′, C′, E′, F′)
into the mice and β-galactosidase staining performed on the embryos. Panels A–C and
gniﬁcations from the respective region between diencephalon and mesencephalon.
typic variability.
423M. Wolf et al. / Developmental Biology 332 (2009) 418–428both at 9.5 dpc (Figs. 4E, F) and at 11.5 dpc (Figs. 4E′, F′) arguing that
processes at this border may be disturbed.
Wnt1 expression is anteriorly expanded in Oct-6brn-1/brn-1 embryos
With forebrain defects being already pronounced at 9.5 dpc, we
extended our studies to earlier stages of development. At 8.25 dpc, the
anterior region of the closing neural tube still appeared morphologi-
cally normal and Shh expression was comparable between wildtype
and Oct-6brn-1/brn-1 embryos (Figs. 5A, B). Pax6 expression, in contrast,
was already strongly reduced and restricted to the anterior most
region (Figs. 5C, D). At the same time,Wnt1 expressionwas anteriorly
expanded (Figs. 5E, F).
The expanded Wnt1 expression caught our attention as previous
studies had shown an essential role for Wnt signalling in the
speciﬁcation of posterior-to-anterior fates within the neural plate.
Compared to the midbrain, Wnt1 levels must be downregulated in the
forebrain. As a consequence, the diencephalon will develop from the
region with reduced Wnt1 levels rostrally adjacent to the midbrain
and the telencephalon from the Wnt-free rostralmost zone (Kiecker
and Niehrs, 2001; Niehrs, 1999). Considering the alterations at the
border between midbrain and forebrain and the expanded Wnt1
expression at 8.25 dpc, we also investigated Wnt1 expression in Oct-
6brn-1/brn-1 embryos at 9.5 dpc (Figs. 6A–G) and 10.5 dpc (Figs. 6A′–E′).
At both embryonic ages,Wnt1 is strongly expressed in the wildtype in
two regions of the midbrain, its dorsal midline and a caudal stripe
bordering the hindbrain (Figs. 6A, D, A′, D′). In Oct-6brn-1/brn-1
embryos, the caudal stripe appeared broadened (Figs. 6B, C, and B′, C′)
in line with results from Fgf8 and En1 in situ hybridizations (Fig. 3). In
contrast, dorsal midline staining was not signiﬁcantly altered in the
midbrain (Figs. 6B, C, E, and B′, C′, E′).
Inspection of wildtype embryos furthermore revealed that
expression at the dorsal midline continued at reduced levels intoFig. 5. Expression of fore- and midbrain markers in Oct-6brn-1/brn-1 embryos at 8.25
dpc. Whole mount in situ hybridizations were performed on wildtype (A, C, E) and
Oct-6brn-1/brn-1 (B, D, F) embryos at 8.25 dpc using antisense riboprobes against Shh
(A, B) Pax6 (C, D), and Wnt1 (E, F). Ventral (A, B, E, F) and lateral views (C, D) are
presented.the forebrain and disappeared at the transition from diencephalon to
telencephalon (Figs. 6A, A′, D, D′). As a consequence, there was co-
expression of Wnt1 and Pax6 in the diencephalon, whereas the
telencephalon was only stained for Pax6 (Fig. 6F). In Oct-6brn-1/brn-1
embryos, however, the dorsal midline expression extended signiﬁ-
cantly farther rostrally than in the wildtype and at higher levels (Figs.
6B, B′, E, E′). In the most affected animals, Wnt1 expression in the
dorsal midline continued to the rostral tip of the brain (Figs. 6C, C′) so
that the remaining Pax6 expression overlapped completely withWnt1
(Figs. 6G, G′). Wnt1 dysregulation was not observed in Oct-6−/− or
Oct-6-/brn-1 embryos (data not shown) in line with the absence of a
forebrain defect in these genotypes.
In situ hybridizations detected a similar expansion of Wnt3a
expression into the anterior most brain regions at 9.5 dpc and
conﬁrmed the overall disturbance of Wnt signalling (Figs. 6H, I).
Bmp4 expression in the dorsal midline was similarly expanded,
whereas ventral expression was strongly reduced (Figs. 6J, K). This
indicates that several signalling pathways involved in forebrain
development are affected and that the cause of the forebrain defect
in Oct-6brn-1/brn-1 embryos is complex. Nevertheless, altered Wnt
signalling due to anteriorly expanded Wnt1 expression likely con-
tributes as a major factor.
Spatial Brn-1 expression is strongly altered in Oct-6brn-1/brn-1 brains
As the forebrain defect in Oct-6brn-1/brn-1 embryos was clearly not a
consequence of missing Oct-6 expression, but rather caused by ectopic
Brn-1 expression, we investigated in what respect the Brn-1 expres-
sion differed between wildtype and Oct-6brn-1/brn-1 embryos. In the
wildtype, Brn-1 was expressed throughout the developing brain. At
9.5 dpc, Brn-1 expression decreased in a caudal to rostral gradient
(Fig. 7B), whereas there was strong Brn-1 expression throughout all
brain regions at 11.5 dpc (Fig. 7B′). Oct-6 transcripts, on the other
hand, were strongly enriched at 9.5 dpc in the diencephalon and in an
oval patch in the ventral telencephalon (Fig. 7A) (Alvarez-Bolado et
al., 1995). Strong Oct-6 expression in the diencephalon also persisted
at 11.5 dpc (Fig. 7A′). In embryos carrying an Oct-6brn-1 allele, the Brn-
1 expression pattern equals the combined Oct-6 and Brn-1 expression
in the wildtype at both 9.5 dpc and 11.5 dpc (Figs. 7C, C′).
The most conspicuous difference between Brn-1 expression in
wildtype and Oct-6+/brn-1 or Oct-6brn-1/brn-1 brains are the strongly
increased expression levels in the diencephalon (compare Figs. 7, B′
to Figs. 7C, C′) that overlap with the Wnt1 expression domain (Figs.
7D, D′). Ectopic Brn-1 expression from a single Oct-6brn-1 allele
already exceeds endogenous Brn-1 expression in the diencephalon
signiﬁcantly.
To get a more general impression of class III POU expression in the
developing brain, we also performed in situ hybridizations with a probe
speciﬁc for Brn-2 (Figs. 8A–C, and A′–C′). These studies revealed that
there is additional expression of Brn-2 throughout the developing brain.
At 9.5 dpc, Brn-2 was expressed at signiﬁcant levels in wildtype
diencephalon, mesencephalon and hindbrain, but only weakly in the
forming telencephalon (Fig. 8A). At 10.5 dpc, Brn-2 expression was also
clearly visible in the telencephalon (Fig. 8A′). Similar data were also
obtained in age-matchedOct-6brn-1/brn-1 embryos (Figs. 8B, C, and B′, C′).
These studies furthermore gave no indication that Brn-2 (or Brn-4)
expression was signiﬁcantly altered in Oct-6brn-1/brn-1 embryos com-
pared to the wildtype (Figs. 8A–C, and A′–C′ and data not shown).
Oct-6 and Brn-1 differentially inﬂuence Wnt1 expression
The upregulation of Brn-1 in the diencephalon of Oct-6brn-1/brn-1
embryos correlated with the rostrally expandedWnt1 expression and
argued for a causal relationship. Both Emx2 and Six3 have previously
been shown to function as negative regulators of Wnt1 expression in
the forebrain (Lagutin et al., 2003; Ligon et al., 2003). As Emx2
Fig. 6. Expression of Wnt and Bmp genes in Oct-6brn-1/brn-1 embryos. Whole mount in situ hybridizations were performed on wildtype (A, D, A′, D′, F, H, J) and Oct-6brn-1/brn-1 (B, C,
E, B′, C′, E′, G, G′, I, K) embryos at 9.5 dpc (A–K) and 10.5 dpc (A′–G′) using antisense riboprobes against Wnt1 (A–G, A′–E′), Pax6 (F, G, G′ signal in red),Wnt3a (H, I) and Bmp4 (J,
K). Lateral (A–C, A′–C′, F–K) and top (D, E, D′, E′) views are presented. The picture in panel G′ is a magniﬁcation of panel G. The arrowheads in panels F, G, G′ mark the area in
which Pax6 and Wnt-1 are co-expressed. Arrowheads in panels H,I indicate the anterior boundary ofWnt3 expression, whereas they demarcate dorsal Bmp4 expression in panels J,
K. Differently affected Oct-6brn-1/brn-1 embryos are shown in B, C, B′ and C′ to give an impression of the phenotypic variability.
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and data not shown), it is conceivable that expandedWnt1 expression
is at least partially caused by the loss of Emx2.
To address the role of Six3, we studied whether the altered class III
POU expression would affect Six3 expression. At 9.5 dpc, we detected
Six3 predominantly in the ventral telencephalon of wildtype embryos
(Fig. 8D). At 10.5 dpc, Six3was expressed throughout the telencepha-
lon, andweaker expressionwas nowalso detected in the diencephalon
(Fig. 8D′). In agreement with the general phenotype, Six3 expression
was clearly reduced in the forebrain of Oct-6brn-1/brn-1 embryos at both
ages (Figs. 8E, F, and E′, F′). However, diencephalic Six3 expression
persisted in all Oct-6brn-1/brn-1 embryos, and the relative rate of Six3
expression in telencephalon, diencephalon and mesencephalon was
comparable in wildtype embryos and those Oct-6brn-1/brn-1 embryos
with a milder phenotype (compare Figs. 8D, D′ to Figs. 8E, E′). As the
latter embryos already exhibited an alteredWnt1 expression, it seems
unlikely that the Oct-6brn-1 allele exerts its effects via Six3.
We also considered the possibility that Oct-6 and Brn-1 directly
affect Wnt1 expression. Both the promoter region as well as a 3′
enhancer are known to regulate neuroectodermal Wnt1 expression
(Lagutin et al., 2003; Rowitch et al., 1998). Sequence inspection of
both regions revealed the presence of two octamer sequences as
potential binding sites for POU proteins in the promoter region of the
Wnt1 gene, whereas no obvious binding motif could be identiﬁed in
the enhancer region. The promoter sites were localized at positions
−1466 and −955 relative to the transcriptional start site (Fig. 9A).
Both the distal site at position−1466 and the proximal site at postion−955 bound Oct-6 and Brn-1 strongly in electrophoretic mobility
shift assays independent of whether the class III POU protein was
supplied as full length protein or truncated version (Fig. 9B). The
proximal site furthermore appeared to have a somewhat higher
binding afﬁnity for Brn-1 than for Oct-6.
To address whether these sites indeed interact with Brn-1 and Oct-
6 in vivo, we performed immunoprecipitation experiments on
crosslinked chromatin of 10.5 dpc-old whole embryonic brains from
wildtype mice with antibodies directed against Brn-1 and Oct-6. In
contrast to control IgG, both speciﬁc antibodies immunoprecipitated
fragments from crosslinked chromatin that encompassed the octamer
elements (Fig. 9C), thus indicating that both octamer elements are
indeed bound in vivo by Brn-1 and Oct-6.
To analyze the effect of both class III POU proteins on Wnt1
expression, luciferase reporter gene assays were performed in
transiently transfected HEK 293 cells (Figs. 9D– G). In all experiments,
we consistently observed a negative effect of class III POU proteins on
Wnt1 expression. This repressive effect was milder, when luciferase
reporter gene expression was driven by a short version of the Wnt1
promoter that contained only the proximal octamer site (Fig. 9D), and
more pronounced, when the luciferase reporter was under the control
of a long version of the Wnt1 promoter that contained both octamer
elements (Fig. 9E). It was furthermore lost when both binding sites for
class III POU proteins were destroyed by site directed mutagenesis
(Fig. 9F). The additional presence of the Wnt1 enhancer in the
luciferase reporter construct did not inﬂuence the repressive POU
protein effect qualitatively or quantitatively (Fig. 9G), consistent with
Fig. 7. Expression of Brn-1 from the Oct-6brn-1 allele. Whole mount in situ hybridizations
were performed onwildtype (A, B, A′, B′), Oct-6+/brn-1 (C, C′) and Oct-6brn-1/brn-1 (D, D′)
embryos at 9.5 dpc (A–D, D′) and 11.5 dpc (A′–C′) using antisense riboprobes against
Oct-6 (A, A′), Brn-1 (B, C, B′, C′ signal in black, D, D′ signal in red) and Wnt1 (D, D′).
Lateral (A–D, A′–C′) and top (D′) views are presented.
Fig. 8. Expression of Brn-2 and Six3 in Oct-6brn-1/brn-1 embryos. Whole mount in situ hybridiza
embryos at 9.5 dpc (A–F) and 10.5 dpc (A′–F′) using antisense riboprobes against Brn-2 (A–C, A
embryos are shown to give an impression of the phenotypic variability.
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ingly, Brn-1 was a weaker repressor than either Oct-6 or Brn-2 on all
reporter constructs and in every experiment (Figs. 9D–G), arguing
that the repressive effect of class III POU proteins on neural Wnt1
expression is less in Oct-6brn-1/brn-1 embryos than in the wildtype. This
effect is particularly relevant in those regions that normally express
high levels of Oct-6 such as the diencephalon at 9.5 dpc.
Discussion
The transcription factor Brn-1, when introduced into Schwann
cells, fully rescues the Oct-6 dependent differentiation defect
(Friedrich et al., 2005). Oct-6 and the highly related Brn-1 thus
function very similarly during Schwann cell development in the PNS
and may very well be functionally equivalent in this cell type. CNS
development, in contrast, is severely disturbedwhen Oct-6 is replaced
by Brn-1 in the mouse. The two related class III POU proteins are
therefore not functionally equivalent in the CNS. This argues for
tissue-speciﬁc differences in functional equivalence of closely related
transcription factors.
The observed phenotype is characterized by truncation of the
forebrain. It had previously gone unnoticed because the phenotype
became obvious only after backcrossing on a clean C57Bl/6J back-
ground. Similar phenotypes have been observed in several mouse
mutants. These include not only mouse mutants in which genes
intrinsically required for forebrain development are affected (Lagutin
et al., 2003; Martinez-Barbera and Beddington, 2001), but also mouse
mutants in which genes involved in the development of the anterior
visceral endoderm such as Otx2, Lim1 and Hex are mutated (Martinez-
Barbera and Beddington, 2001; Perea-Gomez et al., 2001; Shawlot et
al., 1999). Missing inhibition of BMP or Wnt signalling also leads to
severe forebrain truncations as evident from mice homozygously for
both BMP antagonists chordin and noggin (Bachiller et al., 2000) or
Dkk1-deﬁcient mice (Mukhopadhyay et al., 2001).
That derepression of Wnt signalling causes forebrain truncations
(Heisenberg et al., 2001; Kiecker and Niehrs, 2001; Lagutin et al.,
2003), was particularly interesting in the context of Oct-6brn-1/brn-1
mice, as we observed rostrally expandedWnt1 andWnt3a expression
in this mouse mutant. Considering that we also obtained evidence for
altered Bmp signalling, we have to assume that multiple signallingtions were performed on wildtype (A, D, A′, D′) and Oct-6brn-1/brn-1 (B, C, E, F, B′, C′, E′, F′)
′–C′), and Six3 (D–F, D′–F′). Lateral views are presented. Differently affectedOct-6brn-1/brn-1
Fig. 9. Differential effect of Oct-6 and Brn-1 on Wnt1 expression. (A) Schematic representation of the Wnt1 gene locus including promoter, coding (black part of the bar) and
downstream region with the neural plate enhancer (enh). The short (sWnt1) and long (lWnt1) versions of the Wnt1 promoter that were used to generate luciferase reporter
constructs psWnt1-luc and plWnt1-luc are marked. Distal (−1466) and proximal (−955) octamer sites in theWnt1 promoter region are depicted as boxes. They are mutated in the
plWnt1-delOct-luc luciferase reporter. (B) Electrophoretic mobility shift assays with radiolabelled oligonucleotides identical in sequence to the distal and proximal octamer sites of
theWnt1 promoter and extracts containing full length (ﬂ) or shortened versions (ΔC, ΔNC) of Oct-6 and Brn-1. Protein–DNA complexes of characteristic mobility were obtained in all
cases. −, no extract added; c, control extract. (C) Immunoprecipitation was performed on formaldehyde-ﬁxed chromatin from whole mouse embryonic brain at 10.5 dpc in the
presence of antibodies. In addition to control IgGs (IgG), antisera speciﬁcally directed against Brn-1 (α-Brn-1) and Oct-6 (αOct-6) were employed. PCR was applied on the
immunoprecipitate to detect fragments containing either the distal (−1566 to −1312) or the proximal (−1002 to −768) octamer element of the Wnt1 promoter. The same
fragments were also detected in 1/20 of the material used for immunoprecipitation (input). (H2O), water control. (D–G) Transient transfections were performed in HEK 293 cells
using the psWnt1-luc (D), the plWnt1-luc (E), the plWnt1-delOct-luc (F) and an additional psWnt1-luc-enh reporter plasmid that carried both the short version of the Wnt1
promoter as well as the 3′ neural plate enhancer (G). Expression plasmids for Oct-6, Brn-1 and Brn-2 were co-transfected as indicated below the bars. Transactivation rates are
presented as fold inductions±SEM. Luciferase activities were determined in three experiments each performed in duplicates. (H) A model is presented to explain different Wnt1
expression levels in the diencephalon of wildtype, Oct-6−/−, Oct-6-/brn-1 and Oct-6brn-1/brn-1 embryos as a consequence of differential promoter occupancy and ensuing repression by
the respectively occurring class III POU proteins Oct-6 (cyan rhomboid), Brn-1 (red triangle) and Brn-2 (yellow circle).
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6brn-1/brn-1 mice. Altered Wnt signalling is clearly one of them.
Wnt signalling in the forebrain both depends on the activity of
antagonistic factors as well as on the rate ofWnt gene expression. We
observed that the Wnt1 and Wnt3a expression territories were
expanded and that expression levels were increased in the forebrain
of Oct-6brn-1/brn-1 embryos. Brain expression of Wnt1 and Wnt3a
overlaps with the expression domain of several class III POU
proteins including Brn-1, Brn-2 and Oct-6. It is thus possible that
class III POU proteins exert their inﬂuence directly on Wnt
expression, although indirect mechanisms such as the loss of
Emx2 expression in Oct-6brn-1/brn-1 forebrains may also contribute.
In linewith adirect inﬂuenceof class III POUproteinsonWntexpression,
two octamer elements were identiﬁed in the Wnt1 promoter and
veriﬁed as potential binding sites for class III POU proteins inelectrophoretic mobility shift assays. Chromatin immunoprecipitation
furthermore conﬁrmed the actual presence of both Brn-1 and Oct-6 on
theWnt1 promoter in the region where the octamer sites were found.
Taking the highly similar DNA binding characteristics of class III
POU proteins into account (Schreiber et al., 1997), it is not surprising
that Wnt1 promoter binding is not speciﬁc to one particular POU
protein. Promoter occupancy will thus strongly depend on the relative
amounts of the various class III POU proteins present in a particular
brain region. In the posterior forebrain region, i.e. the diencephalon,
Oct-6 is normally present at high levels at 9.5 dpc to 10.5 dpc similar to
Brn-2. Amounts of Brn-1, in contrast, are relatively low, arguing that
the Wnt-1 promoter will predominantly be occupied by Oct-6 and
Brn-2 (Fig. 9H).
In Oct-6brn-1/brn-1 embryos, however, occupancy will be altered
such that Brn-1 is now prominently bound to the Wnt1 promoter in
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Oct-6mousemutants, such as Oct-6-/brn-1 and Oct-6-/-will be different
from that in the Oct-6brn-1/brn-1 genotype. Importantly, none of the
othermutantswill have asmuch Brn-1 bound to theWnt1 promoter in
the posterior forebrain as the Oct-6brn-1/brn-1 mutant (Fig. 9H).
Although class III POU proteins predominantly activate transcrip-
tion (Bermingham et al., 2002; Ghislain and Charnay, 2006; Renner et
al., 1994; Schreiber et al., 1997; Tanaka et al., 2004), several data point
to additional repressive functions (He et al., 1991; Monuki et al., 1990)
(JRB, unpublished data). Thus, class III POU proteins likely function
both as transcriptional activators and repressors. The Wnt1 gene
appears to belong to the repressed target genes, as the activity of the
Wnt1 promoter is downregulated in transient transfections by the
presence of class III POU proteins.
Compared to Oct-6 and Brn-2, Brn-1 is a rather weak repressor of
Wnt1 expression and this difference in the repressive activity may be
important during brain development in Oct-6brn-1/brn-1 embryos. In
cells of the posterior forebrain of these mice, the Wnt1 promoter is
predominantly occupied by Brn-1 instead of Oct-6, and the resulting
lower level of repressionwill lead to derepression of Wnt1 expression
and forebrain truncation (Fig. 9H). Oct-6−/− embryos, in contrast, will
not be affected, as Brn-2 predominantly occupies the Wnt1 promoter
and in contrast to Brn-1 represses promoter activity efﬁciently (Fig.
9H). The importance of the exact amount of Brn-1 in relation to other
class III POU proteins thus nicely explains why the forebrain defect
occurs in the Oct-6brn-1/brn-1 genotype, but not in Oct-6-/brn-1 and
Oct-6−/− mice.
Independent of the exact mode of action, our results clearly show
that Oct-6 and Brn-1 are not as functionally equivalent during brain
development as they were during Schwann cell development.
Whether this has anything to do with a predominantly activating
role during Schwann cell development versus a repressive action
during brain development will have to be analyzed in future studies.
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